slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,369
Current window 33,691-33,720
Pages 1,379
Rows per page 30
Component
33,691-33,720 of 41,369
10
The slide uses a grid of icons with supporting text to communicate six distinct pillars of value.Lazard | Investor Presentation Deck | 46 slides · Lazard
Pitch deck Investor relations Beat · Business ModelLoop · Why Now1 hit
28
The slide outlines a capital allocation framework.Lazard | Investor Presentation Deck | 46 slides · Lazard
Pitch deck Investor relations Beat · The Ask1 hit
16
Includes footnotes detailing definitions of debt, capacity, and interest rates.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations 1 hit
08
The slide uses a three-column layout with circular callouts to present demographic and health statistics.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
10
The slide uses a visual comparison between telomere targeting (left) and PD-1/PD-L1 checkpoint inhibition (right).MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · SolutionLoop · Pattern Hunter1 hit
21
The plot highlights long-term benefit post-therapy and low mortality rates in the cohort.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
34
Includes details on options, warrants, and insider ownership percentage.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Team1 hit
07
The slide outlines the technical workflow from sample collection to patient report generation.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
11
Uses a visual timeline/process flow to explain the biological progression of CRC.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
12
AA = Advanced Adenoma; CRC = Colorectal Cancer. Data source cited at bottom.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
17
Includes a highlighted box emphasizing the performance of the DNA+mRNA+FIT test for CRC and AA.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
21
Slide 21 of a pitch deck.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
07
The slide outlines the technical workflow from sample collection (FIT tube and DNA stabilization tube) through analysis to the final patient report.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
11
Uses a visual timeline/process flow to explain the disease progression.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
13
The slide uses a process flow to demonstrate the technical workflow of the diagnostic test.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations Beat · Solution1 hit
18
Includes a highlighted box emphasizing the primary performance metrics for CRC and AA detection.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
22
Mainz Biomed NV | Investor Presentation Deck | 28 slidesMainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
26
Includes unaudited financial results and balance sheet data.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
14
The slide uses donut charts to visualize the distribution of milestone events across IND, Pre-Pivotal, and Pivotal or Later phases.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit
05
Includes footnotes explaining specific line items and the basis of comparison.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In1 hit
09
The table compares specific financial ratios (NCOs, Cumulative losses, NPAs, NPLs, ALLL) across three groups.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In1 hit
10
The chart highlights NYCB's consistently lower non-performing loan ratios compared to the industry benchmark.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In1 hit
17
The slide combines a bar chart showing portfolio size with a table of origination and charge-off data, alongside a summary of portfolio characteristics.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · Executive SummaryLoop · Golden Circle1 hit
09
Includes a breakdown of board members by status, expertise, and gender.Nexters | Investor Presentation Deck | 18 slides · GDEV
Pitch deck Investor relations Beat · Team1 hit
05
The slide uses a consistent color-coding for metrics (orange for Revenue, brown for Income, blue for EBITDA).Nexters | Results Presentation Deck | 11 slides · GDEV Inc.
Conference presentation Investor relations 1 hit
04
Slide 4 of a pitch deck.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit
12
The slide uses a medical illustration to map specific TRK receptor inhibition side effects to anatomical locations.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
27
Includes clinical trial data cut-offs and patient enrollment numbers.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
39
The chart displays patient-level data categorized by dose (15mg to 200mg) and mutation type, highlighting the efficacy of the drug in clearing specific ALK mutations.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
51
Slide 51 of a pitch deck.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit